Single-disulfide conopeptide czon1107, an allosteric antagonist of the human 34 nicotinic acetylcholine receptor

HIGHLIGHTS

  • who: Yuan Ma and collaborators from the Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Technology, Qingdao, China have published the research work: Single-Disulfide Conopeptide Czon1107, an Allosteric Antagonist of the Human 34 Nicotinic Acetylcholine Receptor, in the Journal: (JOURNAL) of 29/07/2022
  • what: In this study the binding mode of Czon1107 to hα3β4 nAChR was investigated using molecular dynamics simulations coupled with mutagenesis studies of the peptide and electrophysiology studies on heterologous hα3β4 nAChRs.
  • how: The authors obtained the initial model suggesting Czon1107 is . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?